Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Market Cap : 2.144B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.226B |
| August 20, 2026 | 2.263B |
| August 19, 2026 | 2.375B |
| August 18, 2026 | 2.311B |
| August 17, 2026 | 2.399B |
| August 14, 2026 | 2.325B |
| August 13, 2026 | 2.329B |
| August 12, 2026 | 2.410B |
| August 11, 2026 | 2.446B |
| August 10, 2026 | 2.460B |
| August 07, 2026 | 2.418B |
| August 06, 2026 | 2.445B |
| August 05, 2026 | 2.354B |
| August 04, 2026 | 2.346B |
| August 03, 2026 | 2.244B |
| July 31, 2026 | 2.195B |
| July 30, 2026 | 2.209B |
| July 29, 2026 | 2.187B |
| July 28, 2026 | 2.169B |
| July 27, 2026 | 2.265B |
| July 24, 2026 | 2.292B |
| July 23, 2026 | 2.254B |
| July 22, 2026 | 2.305B |
| July 21, 2026 | 2.385B |
| July 20, 2026 | 2.321B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.403B |
| July 16, 2026 | 2.374B |
| July 15, 2026 | 2.501B |
| July 14, 2026 | 2.463B |
| July 13, 2026 | 2.587B |
| July 10, 2026 | 2.679B |
| July 09, 2026 | 2.722B |
| July 08, 2026 | 2.819B |
| July 07, 2026 | 2.882B |
| July 06, 2026 | 3.019B |
| July 02, 2026 | 2.849B |
| July 01, 2026 | 2.698B |
| June 30, 2026 | 2.854B |
| June 29, 2026 | 2.808B |
| June 26, 2026 | 2.699B |
| June 25, 2026 | 2.677B |
| June 24, 2026 | 2.769B |
| June 23, 2026 | 2.769B |
| June 22, 2026 | 2.964B |
| June 18, 2026 | 2.578B |
| June 17, 2026 | 2.479B |
| June 16, 2026 | 2.403B |
| June 15, 2026 | 2.549B |
| June 12, 2026 | 2.447B |
| June 11, 2026 | 2.532B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 55.39B |
| Revolution Medicines, Inc. | 45.33B |
| Sana Biotechnology, Inc. | 1.133B |
| Parabilis Medicines, Inc. | 4.759B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
Market Cap Related Metrics
| Price to Book Value | 1.917 |
| Price | 16.54 |
| Earnings Yield | -10.22% |